• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交界性浆液性卵巢肿瘤的保留生育功能手术:1例报告

Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

作者信息

Mohapatra Ipsita, Samantaray Subha R, Harshini Nikku

机构信息

Obstetrics and Gynecology, All India Institute of Medical Sciences, Kalyani, Kalyani, IND.

Obstetrics and Gynecology, Prathima Institute of Medical Sciences, Karimnagar, IND.

出版信息

Cureus. 2022 Apr 13;14(4):e24128. doi: 10.7759/cureus.24128. eCollection 2022 Apr.

DOI:10.7759/cureus.24128
PMID:35573497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9106565/
Abstract

Borderline ovarian tumors (BOTs) are tumors with low malignant potential and have an excellent prognosis. They are distinct by an epidemiological shift toward younger women. Fertility-sparing surgery is considered the gold standard in young patients presenting with BOTs. Spontaneous conception has been reported after conservative surgery with no enhanced risk of mortality or morbidity from disease progression during pregnancy. The prognosis of BOTs is very good; however, a small proportion of these tumors may recur and show malignant transformation. Timely follow-up of the patients is required for timely detection of any recurrence. We are presenting here a case of a 23-year-old woman diagnosed with BOT. The patient was nulliparous and hence was the appropriate candidate for fertility-sparing surgery. She underwent unilateral salpingo-oophorectomy and is now on regular follow-up.

摘要

卵巢交界性肿瘤(BOTs)是具有低恶性潜能的肿瘤,预后良好。它们的特点是发病有向年轻女性转移的流行病学趋势。对于患有BOTs的年轻患者,保留生育功能的手术被认为是金标准。据报道,保守手术后自然受孕,孕期疾病进展导致的死亡或发病风险并未增加。BOTs的预后非常好;然而,这些肿瘤中有一小部分可能会复发并发生恶性转化。需要对患者进行及时随访以便及时发现任何复发情况。我们在此呈现一例23岁被诊断为BOT的女性病例。该患者未生育,因此是保留生育功能手术的合适人选。她接受了单侧输卵管卵巢切除术,目前正在定期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/b20761082360/cureus-0014-00000024128-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/0ad8bdc3f8da/cureus-0014-00000024128-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/b4b4c94a1b0d/cureus-0014-00000024128-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/b20761082360/cureus-0014-00000024128-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/0ad8bdc3f8da/cureus-0014-00000024128-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/b4b4c94a1b0d/cureus-0014-00000024128-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c74/9106565/b20761082360/cureus-0014-00000024128-i03.jpg

相似文献

1
Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.交界性浆液性卵巢肿瘤的保留生育功能手术:1例报告
Cureus. 2022 Apr 13;14(4):e24128. doi: 10.7759/cureus.24128. eCollection 2022 Apr.
2
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).卵巢交界性肿瘤:法国国家妇产科医师学会(CNGOF)指南
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20.
3
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.交界性卵巢肿瘤:法国 CNGOF 指南。第 2 部分。手术管理、随访、激素替代治疗、生育管理和保存。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2.
4
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.女性的诉求:交界性卵巢肿瘤患者的保留生育功能手术与妊娠结局
Eur J Surg Oncol. 2020 May;46(5):888-892. doi: 10.1016/j.ejso.2019.11.001. Epub 2019 Nov 3.
5
Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.卵巢交界性肿瘤的保守性手术:一项侧重于复发风险的荟萃分析
Eur J Cancer. 2015 Mar;51(5):620-31. doi: 10.1016/j.ejca.2015.01.004. Epub 2015 Feb 3.
6
Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.复发性交界性卵巢肿瘤患者的二次保留生育功能手术和生育结局。
Arch Gynecol Obstet. 2022 Oct;306(4):1177-1183. doi: 10.1007/s00404-022-06431-5. Epub 2022 Mar 23.
7
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.临床病理和手术因素对年轻患者(≤40 岁)交界性卵巢肿瘤复发和妊娠的影响。
BMC Cancer. 2018 Nov 21;18(1):1147. doi: 10.1186/s12885-018-4932-2.
8
Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis.保留生育功能手术与非保留生育功能手术治疗交界性卵巢肿瘤术后复发率的评估:一项回顾性分析结果
Healthcare (Basel). 2023 Jul 3;11(13):1922. doi: 10.3390/healthcare11131922.
9
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.年轻交界性卵巢肿瘤(BOTs)患者的保留生育功能手术:单机构经验
J Ovarian Res. 2016 Mar 18;9:16. doi: 10.1186/s13048-016-0226-y.
10
The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age.育龄期女性交界性卵巢肿瘤(BOTs)的挑战性管理。
Front Surg. 2022 Aug 23;9:973034. doi: 10.3389/fsurg.2022.973034. eCollection 2022.

本文引用的文献

1
Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.韩国全国范围内基于人群的交界性卵巢肿瘤患病率和趋势的研究。
Sci Rep. 2021 May 27;11(1):11158. doi: 10.1038/s41598-021-90757-8.
2
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.年龄相关的交界性卵巢肿瘤(BOT)的临床特征和结局差异:来自 Arbeitsgemeinschaft Gynaekologische Onkologie(AGO)ROBOT 研究的子分析结果。
Ann Oncol. 2014 Jul;25(7):1320-1327. doi: 10.1093/annonc/mdu119. Epub 2014 Mar 11.
3
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
卵巢交界性肿瘤:妇科肿瘤学协作组(AGO)研究组的一项队列研究。
Eur J Cancer. 2013 May;49(8):1905-14. doi: 10.1016/j.ejca.2013.01.035. Epub 2013 Mar 13.
4
Diagnosis, treatment, and follow-up of borderline ovarian tumors.交界性卵巢肿瘤的诊断、治疗和随访。
Oncologist. 2012;17(12):1515-33. doi: 10.1634/theoncologist.2012-0139. Epub 2012 Sep 28.
5
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.超声主观评估优于肿瘤恶性风险指数(RMI)或卵巢恶性肿瘤算法(ROMA),可用于鉴别附件良恶性肿块。
Eur J Cancer. 2012 Jul;48(11):1649-56. doi: 10.1016/j.ejca.2011.12.003. Epub 2012 Jan 5.
6
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.荷兰大样本队列研究中体外受精卵巢刺激后交界性和浸润性卵巢肿瘤的风险
Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26.
7
Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours.与卵巢切除术相比,膀胱切除术治疗交界性卵巢肿瘤的肿瘤学和生殖结局。
Hum Reprod. 2011 Aug;26(8):2008-14. doi: 10.1093/humrep/der119. Epub 2011 Apr 21.
8
Risk factors for recurrence of ovarian borderline tumors.卵巢交界性肿瘤复发的危险因素。
Gynecol Oncol. 2011 Mar;120(3):480-4. doi: 10.1016/j.ygyno.2010.11.016. Epub 2010 Dec 10.
9
How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary.如何随访晚期交界性肿瘤?II-III 期浆液性卵巢交界性肿瘤大系列中复发的诊断模式。
Ann Oncol. 2011 Mar;22(3):631-635. doi: 10.1093/annonc/mdq414. Epub 2010 Aug 16.
10
Diagnosis and treatment of borderline ovarian neoplasms "the state of the art".卵巢交界性肿瘤的诊断与治疗 “最新进展”
Eur J Gynaecol Oncol. 2009;30(5):471-82.